CRC has an immunosuppressive TME which stops the event of a highly effective response to ICB therapies. You can find As a result an urgent really need to recognize the ways reprogram this suppressive TME so that you can improve immunotherapy efficacy. In The existing research, we applied CRISPR KO screens to discover genes that sensitize CRC to ant